METHOD OF TREATING MULTIPLE SCLEROSIS IN CHILDREN Russian patent published in 2016 - IPC A61K38/20 A61K38/21 A61K39/395 A61P25/28 

FIELD: medicine.

SUBSTANCE: invention refers to medicine, particularly to neurology, and can be used in medical practice for treating multiple sclerosis (MS) in children. Method involves plasmapheresis, immunocorrecting and antiviral therapy. Herewith 2 times a year with the gap of 6 months 1 session is performed of cascade plasma exchange of one volume of circulating plasma, then intravenously immunoglobulin G is introduced by drop infusion in the dose of 0.2-0.4 g/kg for 2 days. Then intravenously Ronkoleukin is introduced by drop infusion in the dose of 0.5 mg/day for two days followed by prescribing Viferon in the dose of 3 million IU a day 3 times a week for 1 month in relapsing remitting multiple sclerosis and for 3 months in secondary (or primary) progressive multiple sclerosis.

EFFECT: invention usage allows to reduce the frequency of MS exacerbations, reduce indices of disability, reduce the term of treatment.

1 cl, 4 tbl, 3 ex